A spectrum of severity and prevalence of malignant hyperthermia in anesthetized patients with inhalational anesthetic.

  • Abrar Khan Department of Anesthesia, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Muhammad Imran Department of Anesthesia, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Amjad Hayat Khan Department of Anesthesia, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Yaseen Hussain Department of Pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan
  • Fazlullah Khan Faculty of Pharmacy, Capital University of Science and Technology, Islamabad, Pakistan
Keywords: Anesthesia, Inhalation anesthetics, Malignant hyperthermia

Abstract

Introduction: Malignant hyperthermia (MH) or hyperpyrexia is a pharmacogenetic syndrome of skeletal muscles caused by volatile anesthetics such as halothane and depolarized muscle relaxant suxamethonium. The prevalence of MH in Islamabad has not been explored.

Methodology: This was a retrospective study on the severity and prevalence of MH in anesthetized patients with inhalational anesthetics Clinical data from the previous years, i.e. from June 2020 to June 2021, from eight tertiary care hospitals in Islamabad was collected.

Results: Out of 40,900 patients discharged from these hospitals under general anesthesia, only 07 patients were diagnosed with MH due to anesthesia. MH is associated with gender; in our study, more incidence was observed in males than females. Of the seven patients with MH, four (57.14%) were males, and three (42.86%) were females. The prevalence rate of MH was 0.018% due to anesthesia in surgical patients which is approximately 1 per 5842 cases.

Conclusion: This research study concluded that the prevalence rate of MH in Islamabad is 0.018%. The prevalence rate for males is slightly higher than for females. According to this statement, the total number of male patients who got MH was four, and females were three out of 40900 surgical cases under general anesthesia in a specific year of duration. The prevalence of MH due to anesthesia in surgical patients treated in Islamabad hospitals is approximately 1 per 5842 cases. MH risk in males is significantly higher than in females.

Downloads

Download data is not yet available.

Author Biographies

Abrar Khan, Department of Anesthesia, Bashir Institute of Health Sciences, Islamabad, Pakistan

Anesthesia Technologist, Department of Anesthesia, Bashir Institute of Health Sciences, Islamabad, Pakistan

Muhammad Imran, Department of Anesthesia, Bashir Institute of Health Sciences, Islamabad, Pakistan

Anesthesia Technologist, Department of Anesthesia, Bashir Institute of Health Sciences, Islamabad, Pakistan

Amjad Hayat Khan, Department of Anesthesia, Bashir Institute of Health Sciences, Islamabad, Pakistan

Assistant Professor, Department of Anesthesia, Bashir Institute of Health Sciences, Islamabad, Pakistan

Yaseen Hussain, Department of Pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan

Lecturer, Department of Pharmacy, Bashir Institute of Health Sciences, Islamabad, Pakistan

Fazlullah Khan, Faculty of Pharmacy, Capital University of Science and Technology, Islamabad, Pakistan

Assistant Professor, Faculty of Pharmacy, Capital University of Science and Technology, Islamabad, Pakistan

References

Tan J, Dou N, Bai G, Qiu W, Zhao Y. Research Status of Preemptive Analgesia and its Application in Clinical Anesthesia. J Res Nurs Res. 2021; 5(2).

DOI: https://doi.org/10.26689/jcnr.v5i2.1912

Pölönen P, Ruokonen E, Hippeläinen M, Pöyhönen M, Takala J. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000; 90(5):1052-9.

DOI: https://doi.org/10.1097/00000539-200005000-00010

Roy K, Panigrahi MR, Mukhopadhyay B, Bisak S, Biswas BK. Efficacy of preoperative melatonin and ramelteon (melatonin agonist) therapy on dose requirement of propofol for induction of general anaesthesia: A comparative prospective study. Indian J Clin Anaesth. 2020; 7(1):172-6.

DOI: https://doi.org/10.18231/j.ijca.2020.030

Wenger S. Anesthesia and analgesia in rabbits and rodents. J Exot Pet Med. 2012; 21(1):7-16.

DOI: https://doi.org/10.1053/j.jepm.2011.11.010

Gami AS, Olson EJ, Shen WK, Wright RS, Ballman KV, Hodge DO, et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol. 2013; 62(7):610-6.

DOI: https://doi.org/10.1016/j.jacc.2013.04.080

Brady JE, Sun LS, Rosenberg H, Li G. Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001–2005. Anesth Analg. 2009; 109(4):1162-6.

DOI: https://doi.org/10.1213/ane.0b013e3181ac1548

Hadzic A, Sala-Blanch X, Xu D. Ultrasound guidance may reduce but not eliminate complications of peripheral nerve blocks. Am Society Anesthet. 2008; 108(4):557-8.

DOI: https://doi.org/10.1097/ALN.0b013e318168efa1

Strazis KP, Fox AW. Malignant hyperthermia: a review of published cases. Anesth Analg. 1993; 77(2):297-304.

DOI: https://doi.org/10.1213/00000539-199308000-00014

Suyama H, Kawamoto M, Yuge O. Prevention and treatment of malignant hyperthermia in certified training hospitals in Japan: a questionnaire. J Anesth. 2002; 16:207-10.

DOI: https://doi.org/10.1007/s005400200026

Larach MG, Klumpner TT, Brandom BW, Vaughn MT, Belani KG, Herlich A, et al. Succinylcholine use and dantrolene availability for malignant hyperthermia treatment: database analyses and systematic review. Anesthesiology. 2019; 130(1):41-54.

DOI: https://doi.org/10.1097/ALN.0000000000002490

Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007–2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States. Anesth Analg. 2014; 119(6):1359-66.

DOI: https://doi.org/10.1213/ANE.0000000000000421

Shafer SL, Dexter F, Brull SJ. Deadly heat: economics of continuous temperature monitoring during general anesthesia. Anesth Analg. 2014; 119(6):1235-7.

DOI: https://doi.org/10.1213/ANE.0000000000000487

Lu Z, Rosenberg H, Brady JE, Li G. Prevalence of malignant hyperthermia diagnosis in New York state ambulatory surgery center discharge records 2002 to 2011. Anesth Analg. 2016; 122(2):449-53.

DOI: https://doi.org/10.1213/ANE.0000000000001054

Ho PT, Carvalho B, Sun EC, Macario A, Riley ET. Cost-benefit analysis of maintaining a fully stocked malignant hyperthermia cart versus an initial dantrolene treatment dose for maternity units. Anesthesiology. 2018; 129(2):249-59.

DOI: https://doi.org/10.1097/ALN.0000000000002231

Wong CA. Dantrolene and malignant hyperthermia carts: do we need them on maternity units?. Anesthesiology. 2018; 129(2):225-7.

DOI: https://doi.org/10.1097/ALN.0000000000002279

Sumitani M, Uchida K, Yasunaga H, Horiguchi H, Kusakabe Y, Matsuda S, et al. Prevalence of malignant hyperthermia and relationship with anesthetics in Japan: data from the diagnosis procedure combination database. AM J Society Anaesthesiol. 2011; 114(1):84-90.

DOI: https://doi.org/10.1097/ALN.0b013e318200197d

Published
2023-07-09
How to Cite
1.
Khan A, Imran M, Khan A, Hussain Y, Khan F. A spectrum of severity and prevalence of malignant hyperthermia in anesthetized patients with inhalational anesthetic. JSTMU [Internet]. 9Jul.2023 [cited 14May2024];6(1):20-4. Available from: https://j.stmu.edu.pk/ojs/index.php/jstmu/article/view/232